Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031388 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kang Chan Choi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea. Hauptthemen laut MEDLINE: Nanoparticles, Vaccines, Liposomes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
mRNA vaccines have emerged as a pivotal tool in combating COVID-19, offering an advanced approach to immunization. A key challenge with these vaccines is their need for extremely-low-temperature storage, which affects their stability and shelf life. Our research addresses this issue by enhancing the stability of mRNA vaccines through a novel cationic lipid, O,O′-dimyristyl-N-lysyl aspartate (DMKD). DMKD effectively binds with mRNA, improving vaccine stability. We also integrated phosphatidylserine (PS) into the formulation to boost immune response by promoting the uptake of these nanoparticles by immune cells. Our findings reveal that DMKD-PS nanoparticles maintain structural integrity under long-term refrigeration and effectively protect mRNA. When tested, these nanoparticles containing green fluorescent protein (GFP) mRNA outperformed other commercial lipid nanoparticles in protein expression, both in immune cells (RAW 264.7 mouse macrophage) and non-immune cells (CT26 mouse colorectal carcinoma cells). Importantly, in vivo studies show that DMKD-PS nanoparticles are safely eliminated from the body within 48 h. The results suggest that DMKD-PS nanoparticles present a promising alternative for mRNA vaccine delivery, enhancing both the stability and effectiveness of these vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
- Regeneration Medicine Research Center, Yonsei University Wonju College of Medicine, Wonju 26426, Republic of Korea.
- Division of Hematology/Oncology, Brown University and Rhode Island Hospital, Providence, RI 02903, USA.
- Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
- Division of Breast Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
ORCID-Profile: Kang Chan Choi, Jin Suk Lee, Moon Jung Choi, Min Woo Kim, Chang-Gun Lee
Förderung
- National Research Foundation of Korea
Zitieren
APA
Choi, K. C., Lee, D. H., Lee, J. W., Lee, J. S., Lee, Y. K., Choi, M. J., Jeong, H. Y., Kim, M. W., Lee, C. G., & Park, Y. S. (2024). Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031388
Vancouver
Choi KC, Lee DH, Lee JW, Lee JS, Lee YK, Choi MJ, et al. Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031388
BibTeX
@article{Choi2024,
author = {Choi, Kang Chan and Lee, Do Hyun and Lee, Ji Won and Lee, Jin Suk and Lee, Yeon Kyung and Choi, Moon Jung and Jeong, Hwa Yeon and Kim, Min Woo and Lee, Chang-Gun and Park, Yong Serk},
title = {Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031388}
}
EUVIMED